KITLG and neoplasm: It is proposed that the high expression of TYRP1 could serve as an indicator of the abnormal activation of transcription regulator microphthalmia-associated transcription factor (MITF), which is phosphorylated by the SCF/KIT pathway, or of the inactivation of anti-oncogenes like p53, which results in tumor progression [48–50].